한국어
English
日本語
中文(简体)
Agrylin Capsule 0.5 mg (Anagrelide Hydrochloride)
0.61mg
Hard capsule · Prescription medication
Takeda Korea Pharmaceutical Co., Ltd.
Anagrelide Hydrochloride is a medication used to treat blood disorders by reducing platelet count.
MFDS ingredient code M246870
Anagrelide Hydrochloride is classified as a platelet production inhibitor. It is primarily used in the treatment of blood disorders where there is excessive platelet production. The purpose of this ingredient is to regulate platelet count and reduce the risk of complications.
Anagrelide Hydrochloride decreases platelet count by inhibiting the differentiation of cells that produce platelets in the bone marrow. This reduces the risk of thrombosis due to excessive platelet levels in the blood, thereby improving blood circulation and preventing the occurrence of complications.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other platelet-reducing agents, Anagrelide Hydrochloride selectively inhibits specific steps in the platelet production process. As a result, it has relatively fewer side effects and is effective in regulating platelet count. Additionally, it belongs to the antitumor drug class, specializing in the treatment of blood disorders.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
7 total
0.61mg
Hard capsule · Prescription medication
Takeda Korea Pharmaceutical Co., Ltd.
0.61mg
Hard capsule · Prescription medication
Yuhan Corporation
1.22mg
Hard capsule · Prescription medication
(Co., Ltd.) Korea Pharmbio
1.22mg
Hard capsule · Prescription medication
Yuhan Corporation
0.61mg
Hard capsule · Prescription medication
(Co., Ltd.) Korea Pharma Bio
1.22mg
Hard capsule · Prescription medication
MacNulty Pharmaceutical Co., Ltd.
0.61mg
Hard capsule · Prescription medication
McNulty Pharmaceuticals Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.